Advancing and strengthening the methodological tools and policies relating to the application and implementation of Health Technology Assessment (HTA)
ADVANCE-HTA is a research project funded by the European Commission’s Research Framework Programme (FP7). It comprises several complementary streams of research that aim to advance and strengthen the methodological tools and practices relating to the application and implementation of Health Technology Assessment (HTA). It is a partnership of 13 Consortium members led by the London School of Economics- LSE Health.
ADVANCE-HTA has as its fundamental objective, the methodological advancement of HTA across a range of settings in Europe, North and Latin America, among others. This is achieved by involving the wider stakeholder community in the debate surrounding decision-making and resource allocation.
At LSHTM, Prof. John Cairns is leading the WP1 called “Assessing Value for Money”. The team at LSHTM is formed by John Cairns and Laia Maynou-Pujolras. The main objective of WP1 is to determine empirically the main factors driving HTA decisions across 10 EU countries, through the following steps: 1) Creation of a specifically designed taxonomy, ranging from system-wide to product-specific variables. 2) Constructing a dataset for HTA decisions from 10 EU countries in three different therapeutic areas: Cancer, Multiple Sclerosis and Rheumatoid Arthritis. 3) Specify an econometric panel data model and interpret the main results.
For more information please visit the ADVANCE-HTA website.